Antifungal susceptibility testing of Exophiala spp.: A head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole

Medical Mycology

Volumn 47, Issue 1, 2009, Pages 41-43

  Fothergill, Annette W ^a   Rinaldi, Michael G ^a   Sutton, Deanna A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antifungal susceptibility testing; CLSI methods; Exophiala species

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; EXOPHIALA; EXOPHIALA ATTENUATA; EXOPHIALA BERGERI; EXOPHIALA DERMATITIDIS; EXOPHIALA JEANSELMEI; EXOPHIALA LECANII CORNI; EXOPHIALA MESOPHILA; EXOPHIALA OLIGOSPERMA; EXOPHIALA PHAEOMURIFORMIS; EXOPHIALA SPINIFERA; EXOPHIALA XENOBIOTICA; FUNGUS ISOLATION; HYPHOMYCETES; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EXOPHIALA; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOSES; PYRIMIDINES; TRIAZOLES;

CHAETOTHYRIALES; EXOPHIALA;

EID: 58149196259     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802512451     Document Type: Article

References (12)

1. Capoor, M., Khanna, G. Nair, D. et al. (2007) Eumycetoma pedis due to Exophiala jeanselmei. Indian J Med Micro, 25, pp. 155-157.
2. Gonzalez-Lopez, MA, Salesa, R. Gonzalez-Vela, MC et al. (2007) Subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a renal transplant recipient. Br J Dermatol, 156, pp. 762-764.
3. Khan, SA, Hasan, AS, Capoor, MR, Varshney, MK and Trikha, V. (2007) Calcaneal osteomyelitis caused by Exophiala jeanselmei in an immunocompetent child. A case report. J Bone Joint Surg (Am), 89, pp. 859-862.
4. Al-Obaid, I., Ahmad, S., Khan, ZU, Dinesh, B. and Hejab, HM. (2006) Catheter-associated fungemia due to Exophiala oligosperma in a leukemic child and review of fungemia cases caused by Exophiala species. Eur J Clin Microbio Infect Dis, 25, pp. 729-732.
5. Clinical and Laboratory Standards Institute (CLSI) (2002) Approved standard CLSI M38-A, Wayne, PA, CLSI
6. Zeng, JS, Sutton, DA Fothergill, AW et al. (2007) Spectrum of clinically relevant Exophiala species in the United States. Med Mycol, 45, pp. 3713-3720.
7. Clinical and Laboratory Standards Institute (CLSI) (2002) Wayne, PA, CLSI
8. Odds, FC, Vranckx, L. and Woestenborghs, F. (1995) Antifungal susceptibility sesting of yeasts: Evaluation of technical variables for test automation. Antimicrob Agents Chemother, 39, pp. 2051-2060.
9. Vitale, RG, De Hoog, GS and Verweij, PE. (2003) In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects. Med Mycol, 41, pp. 301-307.
10. Li, D., Li, R., Wang, D. and Ma, S. (1999) In vitro activities of five antifungal agents against pathogenic Exophiala species. Chin Med J, 112, pp. 484-488.
11. Clancy, CJ, Wingard, JR and Hong Nguyen, M. (2000) Subcutaneous phaeohyphomycosis in transplant recipients: Review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol, 38, pp. 169-175.
12. Meletiadis, J., Meis, JF, de Hoog, GS and Verweij, PE. (2000) In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs. Mycoses, 43, pp. 309-312.